P-621 Concurrent hyperfractionated radiotherapy (Hfx RT) and low-dosedaily carboplatin/paclitaxel (C/P) in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S282
Author(s):  
B. Jeremic ◽  
B. Milicic ◽  
G. Radosavljevic-Asic
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Early Stage ◽  
Small Cell ◽  
Long Term Results ◽  
Small Cell Lung ◽  
Hyperfractionated Radiotherapy
Sign in / Sign up

Export Citation Format

Share Document